In the Media
Press Coverage
INVasset and Anirudh Garg in the financial press — features, columns, and market commentary.
PressHCL Tech vs TCS: Which IT stock to buy today after Q1 results 2025? EXPLAINED
India's IT sector eyes market reactions following Q1FY26 results. Analysts favour TCS over HCL Technologies due to TCS's stronger margins and growth despite HCL's revenue increase, which is marred by profit decline and margin pressures.
Read article (opens in a new tab)
PressSilver flat on profit booking, but bullish sentiment remains strong
In India, silver traded at ₹119 per gram and ₹1,19,000 per kilogram. On the Multi Commodity Exchange (MCX), silver touched a record high of ₹1,15,136 per kg in the previous session.
Read article (opens in a new tab)
PressBattle of the IT Titans: TCS Emerges as Top Pick After Q1 FY26 Results
Dive deep into the Q1 FY26 earnings of HCL Tech and TCS. Our expert analysis reveals why analysts favor TCS in the current market, offering insights into their financial performance, margin profiles, and future prospects. Discover which IT stock could be your next strategic investment.
Read article (opens in a new tab)
PressAnthem Biosciences subscribed 73% on Day 1; Should you subscribe? Check latest GMP
Analysts noted that Anthem Biosciences is targeting over 30% revenue growth in FY25 with EBITDA margins close to 37%, meanwhile, shares of the company are commanding a GMP of around 19%.
Read article (opens in a new tab)
PressSilver rallies to fresh all-time high, nears Rs 1.15 lakh per kg mark; Hindustan Zinc shares up 2%
'Silver isn’t following gold anymore—it’s leading. And this time, its shine comes from utility, not just tradition,' said Harshal Dasani from INVasset PMS.
Read article (opens in a new tab)
PressTravel Food Services IPO listing date today. Here’s what GMP, experts signal on share debut
Travel Food Services IPO GMP: The grey market indicates a potential listing price of ₹1,125, slightly above the IPO price of ₹1,100, say market observers
Read article (opens in a new tab)
PressNSE, NSDL shares slide up to 21% from peaks. What’s behind the selling pressure in unlisted market?
India's unlisted equity market faces a sharp correction. Shares of NSE, NSDL, and Tata Capital decline from recent peaks. HDB Financial's discounted IPO and regulatory actions against Jane Street impact market sentiment. Tata Capital's rights issue adds to valuation concerns. Analysts suggest a broader valuation reset is underway. Investors are advised to be cautious of valuations and growth potential.
Read article (opens in a new tab)
PressAnthem Biosciences IPO GMP hits 17% ahead of issue launch on Monday; Should you subscribe? Check key details
Anthem Biosciences shares will be listed on BSE and NSE on July 21, while Allotment is likely to take place on July 17.
Read article (opens in a new tab)
PressAnthem IPO: High growth, low R&D—is this a long-term bet or a risky buy?
Execution and R&D concerns linger, yet Anthem’s high-margin growth engine makes the IPO hard to ignore.
Read article (opens in a new tab)
PressCrizac IPO listing date today. GMP, analysts signal strong debut of shares in stock market today
Crizac IPO listing date is today, July 9, and the equity shares will be listed on BSE and NSE. Ahead of the share listing today, Crizac IPO GMP today and stock market analysts indicate a decent listing for the equity shares.
Read article (opens in a new tab)
PressSuzlon Energy vs Inox Wind: Both underperforming in 2025, which one is better?
Suzlon Energy is leading India's wind energy sector, outperforming Inox Wind in project execution and financial stability. Suzlon's strong order book and net cash position highlight its financial flexibility. Profitability metrics also favor Suzlon, with higher ROE and ROCE. Investors are showing preference for Suzlon due to its ESG initiatives.
Read article (opens in a new tab)
PressMarket rally boosts stocks of loss-making companies on turnaround hopes
The rally comes amid a recovery phase in markets, with SMIDs climbing back toward their September 2024 highs
Read article (opens in a new tab)
PressAuto, IT stocks in red amid tariff uncertainty; Maruti Suzuki, Tech Mahindra shares down up to 2%
Trump said he will impose an additional 10% tariff with no exceptions on any country aligning itself with what he called the 'Anti-American policies of BRICS'. India is a key member of BRICS.
Read article (opens in a new tab)
PressPharma Stocks: ट्रंप का ऐलान, 4% तक टूट गए फार्मा स्टॉक्स, इस कारण लगा शॉक
Pharma Stocks: अमेरिकी राष्ट्रपति डोनाल्ड ट्रंप के नए टैरिफ चार्ट पर घरेलू मार्केट में फार्मा कंपनियों के शेयर धड़ाम से गिर गए। फार्मा शेयरों की बिकवाली के चलते इसका निफ्टी इंडेक्स निफ्टी फार्मा 1% से अधिक टूटकर 22 हजार के नीचे 21,987.65 तक आ गया।
Read article (opens in a new tab)
PressAurobindo Pharma, Dr Reddy's, Lupin, other pharma stocks tumble up to 3% amid tariff jitters
'A renewed push for 'Buy America' could complicate matters for low-margin generics, and any uptick in regulatory stringency may weigh on sentiment,' said an analyst.
Read article (opens in a new tab)
PressPharma Stocks Slide Up To 3% On US Tariff Concerns; Aurobindo, DRL, Lupin Among Top Losers
Shares of Indian pharma companies fell on July 8 as investor concerns resurfaced following US President Trump’s announcement of new tariff
Read article (opens in a new tab)
PressCrizac's Rs 860-crore IPO subscribed 45% on Day 1: Should you apply?
Crizac IPO: The maiden public issue of the Kolkata-based company entirely comprises an offer for sale (OFS) of shares.
Read article (opens in a new tab)
PressHDFC बैंक की इस कंपनी ने की धमाकेदार लिस्टिंग, क्या आगे भी बनेगा पैसा? यहां है जवाब
HDB फाइनेंशियल सर्विसेज की लिस्टिंग बाजार की उम्मीदों और ग्रे मार्केट प्रीमियम (GMP) के ट्रेंड्स के अनुरूप रही. अब सवाल ये है कि लिस्टिंग के बाद निवेशकों की रणनीति क्या होनी चाहिए?
Read article (opens in a new tab)